Antimicrobial Agents Practice Questions

Q: Inhibition of which of the following vitamins is caused by Isoniazid?

Pyridoxine. **Explanation:** **Mechanism of Pyridoxine (Vitamin B6) Inhibition:** Isoniazid (INH) is a structural analog of pyridoxine. It causes Vitamin B6 deficiency through two primary mechanisms: 1. **Competitive Inhibition:** INH inhibits the enzyme **pyridoxine phosphokinase**, which is essential for converting pyridoxine into its active form, pyridoxal-5-phosphate (PLP). 2. **Chemical Inactivation:** INH reacts with PLP to form **isonicotinyl-hydrazone**, which is then rapidly excreted in the urine. Since PLP is a crucial cofactor for neurotransmitter synthesis (like GABA), its deficiency leads to **peripheral neuropathy**, the most common side effect of INH [1]. **Analysis of Incorrect Options:** * **A. Riboflavin (B2):** Deficiency is typically associated with drugs like chlorpromazine or tricyclic antidepressants, not antitubercular drugs. * **C. Thiamine (B1):** Deficiency (Beriberi/Wernicke-Korsakoff) is primarily associated with chronic alcoholism and loop diuretics, not INH. * **D. Folate (B9):** Folate antagonism is a hallmark of drugs like **Methotrexate, Trimethoprim, and Pyrimethamine**, which inhibit dihydrofolate reductase [3]. **High-Yield Clinical Pearls for NEET-PG:** * **Prophylaxis:** To prevent neuropathy, **10–50 mg/day of Pyridoxine** is co-administered with INH, especially in high-risk groups (alcoholics, diabetics, pregnant women, and malnourished patients) [1]. * **Pharmacogenetics:** **Slow acetylators** are at a much higher risk of developing INH-induced peripheral neuropathy due to higher plasma concentrations of the drug [1], [2]. * **Sideroblastic Anemia:** INH can also cause microcytic anemia because PLP is a cofactor for **δ-ALA synthase**, the rate-limiting enzyme in heme synthesis.

Q: What is the drug of choice for ascariasis?

Albendazole. **Explanation:** **Albendazole** is currently the drug of choice for **Ascariasis** (*Ascaris lumbricoides*). It is a broad-spectrum benzimidazole that acts by inhibiting microtubule polymerization by binding to **β-tubulin**. This leads to the disruption of glucose uptake and energy depletion in the parasite, resulting in its death. **Why Albendazole is preferred:** * **Efficacy:** A single oral dose (400 mg) achieves high cure rates. * **Convenience:** Unlike Mebendazole, which requires a 3-day course, Albendazole is effective as a single dose, ensuring better patient compliance. * **Broad Spectrum:** It is simultaneously effective against other common co-infestations like hookworm and pinworm. **Analysis of Incorrect Options:** * **Mebendazole (C):** While highly effective against Ascaris, it typically requires a twice-daily dose for three days. It is considered a first-line alternative but is secondary to the single-dose convenience of Albendazole. * **Piperazine citrate (A):** It causes flaccid paralysis of the worm by blocking ACh at the neuromuscular junction. It was previously used but is now obsolete due to lower efficacy and potential neurotoxicity. However, it remains a specific choice in cases of **intestinal or biliary obstruction** by Ascaris because it relaxes the worms, allowing them to be expelled without causing further impaction. * **Bephenium hydroxynaphthoate (B):** An older anthelmintic primarily used for hookworms; it is rarely used today due to the availability of safer, more effective benzimidazoles. **NEET-PG High-Yield Pearls:** * **Mechanism of Action:** Inhibition of microtubule synthesis (β-tubulin binding). * **Pregnancy:** Benzimidazoles are generally **contraindicated** in the first trimester (embryotoxic in animals). * **Drug of Choice for Hydatid Disease:** Albendazole is also the DOC for Neurocysticercosis and Hydatid disease (Echinococcosis).

Q: Select the antimicrobial agent that can be used to treat both methicillin-resistant and vancomycin-resistant Staphylococcus aureus infections?

Linezolid. **Explanation:** **Linezolid** is the correct answer because it belongs to the **Oxazolidinone** class of antibiotics, specifically designed to combat multi-drug resistant Gram-positive bacteria. 1. **Mechanism & Efficacy:** Linezolid inhibits protein synthesis by binding to the **23S ribosomal RNA of the 50S subunit**, preventing the formation of the 70S initiation complex. Because its site of action is unique, there is minimal cross-resistance with other drug classes. It is highly effective against **MRSA** (Methicillin-resistant *S. aureus*) and is one of the few oral/IV options for **VRSA** (Vancomycin-resistant *S. aureus*) and **VRE** (Vancomycin-resistant *Enterococci*) [1]. **Why other options are incorrect:** * **Clarithromycin:** A Macrolide that is generally bacteriostatic. While it covers some Gram-positive cocci, resistance is widespread among *Staphylococci*, and it has no activity against MRSA or VRSA. * **Clindamycin:** A Lincosamide used for anaerobic infections and some MRSA strains (if the D-test is negative). However, it is ineffective against VRSA. * **Lincomycin:** Also a Lincosamide (similar to Clindamycin) with a narrower spectrum and lower potency; it cannot treat resistant strains like MRSA or VRSA. **High-Yield NEET-PG Pearls:** * **Side Effects:** Prolonged use (>2 weeks) can lead to **Bone Marrow Suppression** (especially thrombocytopenia) and **Optic/Peripheral Neuropathy**. * **Drug Interaction:** Linezolid is a weak non-selective **MAO inhibitor**. It can precipitate **Serotonin Syndrome** if co-administered with SSRIs. * **Alternative for VRSA:** Other drugs include Daptomycin, Quinupristin-Dalfopristin, and Tigecycline [2].

Q: Which of the following statements about terbinafine is FALSE?

It is used topically only.. **Explanation:** Terbinafine is an **allylamine** antifungal agent that plays a crucial role in treating superficial fungal infections. **1. Why Option D is the Correct Answer (The False Statement):** Terbinafine is **not** used topically only. It has excellent oral bioavailability and is highly lipophilic and keratophilic. When taken orally, it accumulates in high concentrations in the skin, sebum, and nails. This makes **oral terbinafine** the drug of choice for systemic treatment of fungal nail infections (onychomycosis) and extensive tinea corporis. **2. Analysis of Incorrect Options:** * **Option A (Restricted to dermatophytes):** While terbinafine has some activity against *Candida*, its clinical efficacy is primarily and significantly superior against **dermatophytes** (e.g., *Trichophyton*, *Epidermophyton*, and *Microsporum*). * **Option B (Effective in onychomycosis):** Due to its keratophilic nature, it remains in the nail plate for weeks even after stopping therapy. It is considered more effective than griseofulvin or itraconazole for fungal nail infections. * **Option C (Inhibits squalene epoxidase):** This is its primary mechanism of action. By inhibiting this enzyme, it prevents the conversion of squalene to lanosterol. This leads to a **deficiency of ergosterol** (essential for fungal cell membranes) and a **toxic accumulation of squalene**, which is fungicidal. **Clinical Pearls for NEET-PG:** * **Mechanism:** Inhibits Squalene Epoxidase (unlike Azoles, which inhibit 14-α demethylase). * **Nature:** It is **fungicidal** against dermatophytes (Azoles are mostly fungistatic). * **Side Effects:** Most common are GI upset and taste disturbances. Rarely, it can cause hepatotoxicity (monitor LFTs). * **Drug of Choice:** Oral terbinafine is the gold standard for **Onychomycosis**.

Q: All of the following drugs have activity against hepatitis EXCEPT:

Zidovudine. **Explanation:** The core concept tested here is the specificity of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) for different viral polymerases. While many NRTIs are used for both HIV and Hepatitis B (HBV), **Zidovudine (AZT)** is exclusively an anti-retroviral agent with no clinical activity against the Hepatitis B virus. **1. Why Zidovudine is the correct answer:** Zidovudine was the first NRTI approved for HIV. It specifically inhibits the HIV reverse transcriptase enzyme. Unlike other drugs in its class, it does not effectively inhibit the HBV DNA polymerase. Therefore, it has no role in the treatment of any form of viral hepatitis. **2. Why the other options are incorrect:** * **Lamivudine (3TC):** A potent inhibitor of both HIV reverse transcriptase and HBV DNA polymerase. It was the first oral antiviral approved for Chronic Hepatitis B. * **Emtricitabine (FTC):** Structurally related to Lamivudine, it is highly effective against both HIV and HBV. It is frequently used in co-infected patients. * **Telbivudine:** An L-thymidine nucleoside analogue specifically indicated for the treatment of Chronic Hepatitis B. It is not used for HIV. **High-Yield Clinical Pearls for NEET-PG:** * **HBV + HIV Co-infection:** Drugs active against both include **Tenofovir (TDF/TAF)**, **Lamivudine**, and **Emtricitabine**. Tenofovir is currently the preferred backbone for co-infection. * **Entecavir:** A potent anti-HBV drug that should *not* be used as monotherapy in HIV-infected patients because it can select for the M184V mutation in HIV. * **Zidovudine Side Effects:** Remember the "3 Ms": **M**acrocytic anemia (bone marrow suppression), **M**yopathy, and **M**elanonychia (nail pigmentation).

Q: What is the drug of choice for urinary tract infections (UTIs) caused by Pseudomonas?

Ciprofloxacin. **Explanation:** **1. Why Ciprofloxacin is the Correct Answer:** *Pseudomonas aeruginosa* is a notorious Gram-negative pathogen known for its intrinsic resistance to many common antibiotics. **Ciprofloxacin**, a second-generation fluoroquinolone, is the drug of choice for oral treatment of pseudomonal UTIs. Its mechanism involves inhibiting **DNA gyrase (Topoisomerase II)** and **Topoisomerase IV**, preventing bacterial DNA replication. It is highly effective because it achieves high concentrations in the urine and possesses excellent bactericidal activity against most strains of *Pseudomonas*. **2. Why the Other Options are Incorrect:** * **Amoxicillin (Option A):** This is a penicillin that is easily degraded by beta-lactamases. *Pseudomonas* is naturally resistant to amoxicillin. * **Amoxiclav (Option B):** While Clavulanic acid protects amoxicillin from some beta-lactamases, it does not extend the spectrum to include *Pseudomonas*. * **Cefixime (Option C):** This is a 3rd-generation oral cephalosporin. While effective against many Enterobacteriaceae (like *E. coli*), it has **no activity** against *Pseudomonas*. **3. NEET-PG High-Yield Clinical Pearls:** * **Anti-Pseudomonal Cephalosporins:** Remember the "3b and 4" rule: **Ceftazidime** (3b) and **Cefepime** (4th gen) are the cephalosporins active against *Pseudomonas*. * **Anti-Pseudomonal Penicillins:** Piperacillin and Ticarcillin. * **Carbapenems:** Imipenem and Meropenem are active, but **Ertapenem** is the "exception" (it has no activity against *Pseudomonas*). * **Aminoglycosides:** Amikacin is generally the most potent aminoglycoside against *Pseudomonas*. * **Safety Note:** Fluoroquinolones like Ciprofloxacin are contraindicated in pregnancy and children due to the risk of **cartilage damage (arthropathy)**.

Q: In the treatment of Pseudomonas infections, carbenicillin is frequently combined with which of the following agents?

Gentamicin. The correct answer is **Gentamicin**. This combination is a classic example of **pharmacodynamic synergy** used in the management of serious *Pseudomonas aeruginosa* infections [1]. **Why Gentamicin is correct:** Carbenicillin (an antipseudomonal penicillin) and Gentamicin (an aminoglycoside) work together through a synergistic mechanism: 1. **Cell Wall Inhibition:** Carbenicillin inhibits bacterial cell wall synthesis, which increases the permeability of the bacterial membrane [3]. 2. **Enhanced Entry:** This structural damage allows Gentamicin to enter the bacterial cell more easily, where it binds to the 30S ribosomal subunit to inhibit protein synthesis [3]. *Note: These drugs should never be mixed in the same IV bottle/syringe as they are chemically incompatible (aminoglycosides are basic and penicillins are acidic), leading to mutual inactivation.* **Why other options are incorrect:** * **A & D (Penicillin/Amoxicillin):** These are narrow or broad-spectrum penicillins that lack significant activity against *Pseudomonas*. Combining two beta-lactams generally does not provide synergy and may increase the risk of toxicity. * **C (Ciprofloxacin):** While Ciprofloxacin has antipseudomonal activity, it is not the standard "textbook" synergistic partner for carbenicillin in the way aminoglycosides are. **NEET-PG High-Yield Pearls:** * **Synergy Rule:** Always remember: **Cell wall synthesis inhibitor + Aminoglycoside = Synergy.** (e.g., Penicillin + Gentamicin for Enterococcal endocarditis) [2]. * **Antipseudomonal Penicillins:** Include Carboxypenicillins (Carbenicillin, Ticarcillin) and Ureidopenicillins (Piperacillin). Piperacillin is currently the most potent. * **Incompatibility:** Aminoglycosides are physically incompatible with beta-lactams *in vitro*. Administer them at different sites or times.

Q: The HIV fusion inhibitor, enfuvirtide, acts at which site?

Gp 41. **Explanation:** **Enfuvirtide** is a unique antiretroviral drug classified as a **Fusion Inhibitor**. To understand its mechanism, one must recall the steps of HIV entry into the CD4+ T cell [3]: 1. **Attachment:** Viral **gp120** binds to the host **CD4 receptor**. 2. **Co-receptor binding:** gp120 undergoes a conformational change to bind to **CCR5 or CXCR4** [2]. 3. **Fusion:** The transmembrane subunit **gp41** undergoes a structural change (forming a six-helix bundle), which pulls the viral and host membranes together, allowing the viral capsid to enter the cell. **Enfuvirtide** mimics a segment of gp41. It binds to the HR1 (heptad repeat 1) region of **gp41**, preventing the necessary conformational change required for membrane fusion [1]. **Analysis of Incorrect Options:** * **Gp 120:** This is the surface subunit responsible for initial attachment. Drugs like **Fostemsavir** (attachment inhibitor) and **Ibalizumab** (post-attachment inhibitor) target this stage, not enfuvirtide. * **P24:** This is a structural protein that forms the viral **capsid**. It is used as a diagnostic marker in early HIV infection (p24 antigen assay) but is not the target of enfuvirtide. * **CXCR4:** This is a host co-receptor [3]. **Maraviroc** is the drug that acts at the entry stage by binding to the **CCR5** co-receptor (it does not target CXCR4) [2]. **High-Yield NEET-PG Pearls:** * **Route of Administration:** Enfuvirtide is the only HIV drug administered **subcutaneously** (it is a synthetic peptide) [1]. * **Side Effects:** Almost 100% of patients develop **injection site reactions** (nodules, erythema). * **Indication:** Used as "salvage therapy" in treatment-experienced patients with multi-drug resistant HIV [1]. * **Mnemonic:** En**fu**virtide prevents **Fu**sion by targeting gp**41** (think: "41 looks like a needle/spike used for fusion").

Q: Cilastatin is combined with which of the following to increase its duration?

Imipenem. **Explanation:** **1. Why Imipenem is the Correct Answer:** Imipenem is a broad-spectrum carbapenem antibiotic. When administered alone, it is rapidly inactivated in the body by the enzyme **Dehydropeptidase-I (DHP-I)**, located in the brush border of the proximal renal tubules. This metabolism results in low urinary concentrations and the formation of potentially nephrotoxic metabolites. **Cilastatin** is a specific, reversible inhibitor of DHP-I. It is combined with Imipenem to: * Prevent its renal degradation, thereby increasing its plasma half-life and duration of action. * Ensure high therapeutic concentrations in the urine. * Reduce the risk of nephrotoxicity. **2. Why Other Options are Incorrect:** * **Carbenicillin & Penicillin G:** These are penicillins. Their duration of action is typically extended by combining them with **Probenecid**, which inhibits their renal tubular secretion, or by using repository forms (e.g., Benzathine Penicillin). They are not metabolized by DHP-I. * **Cefoperazone:** This is a third-generation cephalosporin. It is primarily excreted via bile and does not require a DHP-I inhibitor. It is frequently combined with **Sulbactam** (a beta-lactamase inhibitor) to enhance its spectrum against resistant bacteria. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic:** "The kill is lastin' with Cilastatin" (It makes Imipenem last longer). * **Newer Carbapenems:** Meropenem, Ertapenem, and Doripenem are **resistant to DHP-I**; therefore, they do *not* require co-administration with Cilastatin. * **Adverse Effect:** Imipenem-Cilastatin carries a higher risk of **seizures**, especially in patients with renal failure or pre-existing CNS lesions. * **Spectrum:** Imipenem is the drug of choice for *Enterobacter* infections and mixed aerobic/anaerobic infections.

Question 1

Inhibition of which of the following vitamins is caused by Isoniazid?

Accepted Answer

Pyridoxine

Answer

Riboflavin

Answer

Thiamine

Answer

Folate

Question 2

What is the drug of choice for ascariasis?

Accepted Answer

Albendazole

Answer

Piperazine citrate

Answer

Bephenium hydroxynaphthoate

Answer

Mebendazole

Question 3

Select the antimicrobial agent that can be used to treat both methicillin-resistant and vancomycin-resistant Staphylococcus aureus infections?

Accepted Answer

Linezolid

Answer

Clarithromycin

Answer

Clindamycin

Answer

Lincomycin

Question 4

Which of the following statements about terbinafine is FALSE?

Accepted Answer

It is used topically only.

Answer

Its activity is restricted to dermatophytes.

Answer

It is effective in onychomycosis.

Answer

It inhibits squalene epoxidase.

Question 5

Use of tadalafil is contraindicated in:

Accepted Answer

Unstable/Symptomatic angina

Answer

Pulmonary arterial hypertension

Answer

Active infections

Answer

Hepatic dysfunction

Question 6

All of the following drugs have activity against hepatitis EXCEPT:

Accepted Answer

Zidovudine

Answer

Lamivudine

Answer

Emtricitabine

Answer

Telbivudine

Question 7

What is the drug of choice for urinary tract infections (UTIs) caused by Pseudomonas?

Accepted Answer

Ciprofloxacin

Answer

Amoxicillin

Answer

Amoxiclav

Answer

Cefixime

Question 8

In the treatment of Pseudomonas infections, carbenicillin is frequently combined with which of the following agents?

Accepted Answer

Gentamicin

Answer

Penicillin

Answer

Ciprofloxacin

Answer

Amoxicillin

Question 9

The HIV fusion inhibitor, enfuvirtide, acts at which site?

Accepted Answer

Gp 41

Answer

Gp 120

Answer

P24

Answer

CXCR4

Question 10

Cilastatin is combined with which of the following to increase its duration?

Accepted Answer

Imipenem

Answer

Carbenicillin

Answer

Cefoperazone

Answer

Penicillin G

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?